In fact, in the murine MC38 colon cancer model (Fig. 5F), the administration of anti-PD-1 antibodies to miR-146b−/− mice significantly delayed tumor growth compared to the administration of anti-PD-1 mAbs to WT mice (Fig. 5G-H). Here, PDCD1 is linked to malignant colon neoplasm.